Agree eMark, the bit that has me excited is the Licensing discussions to start immediately.
If our product works and the early clinical studies have been good indicators.....enhancing nasal air flow by 37%, we will be in the ball park of a half billion dollar market with a more effective product.
There has been a big buyer mopping up in the market, so interesting and positive time ahead IMHO.
The stock is taking a breather (pardon the pun:) but the upward buying will have another leg up it seems.
Eyeknow
DYOR
CGP Price at posting:
14.0¢ Sentiment: Buy Disclosure: Held
